Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
ELITE
Unknown
1,200 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Phase NA Unknown
70 enrolled
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Phase 2 Unknown
62 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
A Study of TY-1091 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
248 enrolled
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Phase 1 Unknown
168 enrolled
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Phase 1 Unknown
24 enrolled
CaVe
Unknown
150 enrolled
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
189 enrolled
HOUSE
Unknown
100 enrolled
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Phase 1 Unknown
96 enrolled
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Phase 2 Unknown
90 enrolled
AMT-151 in Patients With Selected Advanced Solid Tumours
Phase 1 Unknown
30 enrolled
Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients
Phase 4 Unknown
140 enrolled
CCGA
Unknown
15,254 enrolled
Phase 1 First-in-human Study of JS014
Phase 1 Unknown
60 enrolled
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
Phase 1/2 Unknown
72 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Phase 1/2 Unknown
186 enrolled
Clinical Trial of Autologous Tcm Immunotherapy in ICC
Phase 2 Unknown
20 enrolled
PICC
Phase NA Unknown
1,666 enrolled
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
Unknown
2,000 enrolled
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase 1 Unknown
1 enrolled
URODETECT-WP3
Phase NA Unknown
200 enrolled
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase 1 Unknown
156 enrolled
OPTIMUM
Phase 2 Unknown
60 enrolled
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Phase 1 Unknown
29 enrolled
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
Phase NA Unknown
6 enrolled
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
Phase 3 Unknown
320 enrolled
MyProstateScore Equivalency With and Without DRE
Phase NA Unknown
800 enrolled
myCare-102
Unknown
730 enrolled
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
100 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
Long-term Follow-up of RESTORE Study
Unknown
350 enrolled
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
Phase NA Unknown
100 enrolled
UNITY
Unknown
1,000 enrolled
Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)
Phase 2 Unknown
200 enrolled
Collection and Distribution of Biospecimens for Novel Research
Unknown
100,000 enrolled
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Phase 1 Unknown
23 enrolled
Establish ProLung Test Measurement Collection Protocol for Future Studies.
Unknown
500 enrolled
RESTORE
Phase NA Unknown
352 enrolled
OMCAT
Unknown
166,000 enrolled
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Phase 1 Unknown
48 enrolled
Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up
Unknown
50 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
Breast Cancer Liquid Biopsy Trial
Unknown
450 enrolled
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Phase 1/2 Unknown
33 enrolled